Cargando…
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis
There is increasing interest in future, highly-potent ‘pan-TB’ regimens against tuberculosis (TB), that may be equally effective in both drug-susceptible and rifampicin-resistant (RR) forms of TB. Taking the example of India, the country with the world’s largest burden of TB, we show that adoption o...
Autores principales: | Arinaminpathy, Nimalan, Gomez, Gabriela B., Sachdeva, Kuldeep S., Rao, Raghuram, Parmar, Malik, Nair, Sreenivas A., Rade, Kiran, Kumta, Sameer, Hermann, David, Hanson, Christy, Chin, Daniel P., Dewan, Puneet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100958/ https://www.ncbi.nlm.nih.gov/pubmed/32218585 http://dx.doi.org/10.1371/journal.pone.0230808 |
Ejemplares similares
-
Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness
por: Arinaminpathy, Nimalan, et al.
Publicado: (2021) -
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data
por: Arinaminpathy, Nimalan, et al.
Publicado: (2019) -
Modelling the impact of effective private provider engagement on tuberculosis control in urban India
por: Arinaminpathy, Nimalan, et al.
Publicado: (2019) -
Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): Evidence leading to policy enhancement
por: Parmar, Malik M., et al.
Publicado: (2018) -
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis
por: Nair, Sreenivas Achuthan, et al.
Publicado: (2016)